By PathGene Biotech · Technically reviewed by Alex Huang
Dihydroberberine vs Berberine HCl: Evidence and Bulk Ingredient Comparison
Dihydroberberine (DHB, CAS 483-15-8) is a reduced derivative of berberine. Berberine hydrochloride (CAS 633-65-8) is a salt material. They are not interchangeable specifications, and evidence for one does not establish the performance of every commercial batch of the other.
What should a bulk buyer compare first?
| Purchase question | Berberine hydrochloride | Dihydroberberine |
|---|---|---|
| Identity | Specify the hydrochloride, CAS 633-65-8, including water or hydration basis in the offered specification. | Specify DHB, CAS 483-15-8, with its own identity and assay documents. |
| Quality and assay | Review method, reference standard, assay basis, related substances, water and residual solvents. | Review its own method, assay basis and impurity controls; do not copy the hydrochloride COA. |
| Formulation | Evaluate the actual batch in the intended concentration, excipients and processing conditions. | Evaluate dispersion, assay and storage stability in the target formula. |
| Cost comparison | Compare delivered cost for the agreed specification and packaging. | Different study doses do not define a universal dose or cost-equivalent substitution. |
What does the human absorption study establish?
A small randomized crossover pilot involving five men compared berberine and DHB protocols. It measured circulating berberine and glycemic outcomes. Its limited size and short protocol do not establish long-term efficacy or a universal dose conversion. Read the original study record.
Higher exposure to a measured analyte is not automatically a better finished product. A formulation project still needs its own dose rationale, quality requirements and appropriate supporting evidence. The paper’s trial material is not proof that an unrelated commercial batch has identical performance.
Which documents should accompany an evaluation sample?
Match the label, quotation, specification and COA to the same chemical form and batch. Record the method, result basis, impurity limits, packaging and storage instruction. Test the sample in the proposed formula; ask for supporting stability data relevant to the intended use instead of assuming a material is stable in every matrix.
Compare the supplied raw materials
Review the berberine hydrochloride powder and dihydroberberine powder pages separately. Use the quality-document hub for lot-matched documentation. Published raw-material research does not replace supplier qualification or finished-product testing.
Reference and evidence boundary
Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia, Nutrients (2021), DOI 10.3390/nu14010124. This article compares purchasing criteria; it does not provide treatment advice or establish regulatory eligibility in a particular country.
Frequently Asked Questions
Can DHB replace berberine hydrochloride kilogram for kilogram?+
No universal mass-equivalent substitution follows from their names or an absorption study. They have different identities and require their own specifications, formulation testing and use rationale.
Does the human study qualify a PathGene batch?+
No. Published research addresses the tested material and protocol. A offered lot is qualified by its own identity, analytical documents and agreed quality requirements.
Ready to evaluate our products?
Request a sample or send an inquiry — our R&D team responds within 24 hours.
